Chro.80317 | insulinase

  • Computed_GO_Component_IDs:        

  • Computed_GO_Components:        

  • Computed_GO_Function_IDs:  GO:0003824      GO:0046872      

  • Computed_GO_Functions:  catalytic activity      metal ion binding      

  • Computed_GO_Process_IDs:        

  • Computed_GO_Processes:        

  • Curated_GO_Component_IDs:        

  • Curated_GO_Components:        

  • Curated_GO_Function_IDs:        

  • Curated_GO_Functions:        

  • Curated_GO_Processes:        

_IDPredictionOTHERSPmTPCS_Position
Chro.80317OTHER0.9999030.0000860.000011
No Results

  • Fasta :-

    >Chro.80317 MNEVANLFKDELGDLNRGEFIRDETKYNFSFIKSIKVSNVGMLELYQHQKGVIVAFMKTF TICGPSFTHCKLSFTTVPNNNKGIPHALEHVIFNGSKRFPYNDSIDKISNRLCCPYTNAF TIDDSTTFEFECTTEWSLLRMLEVWLDHLFHPILSEESFLTEIVHLNENAEYHGVVYSEV SSFERNYDEVVTTLSKFHTLCESPAEKKKIKLHSTWELYDEITEKYDGSQSSVFSCTGRT TGLQNLSLDELKEFHANFYSLDNMLIFIHGNESININNIFGTIGKFISEAEHVNDNKTCK KIRISDSPINQRPLNRKFCFNENLKEQSFPWHLEIPFPSEEEDLSTISFSWRFGAFSNFK EMLSITVLLHYLCIGNDSPLMKELVEGKSYCSDVDMSNVCEKNRYHQILLQGVETTKINK IVDLFKRIISEFHNGERSFDINDLKCKIEGLYYGHLISLENKTIDTVFNQLSGFINYGIN NMDDLTEYCNLHFIFKKLLSEGLEYWKTLFNKAFCLQKMNILEFVPSKKLSKEMTKRFKE ERKERISKKGKRFFQICKAKLEESIIINKKRAISLEILNNFNISFDLNCIDLNKANITTN LNYSEAKLTEINEGNDIIFKKLNMGYDLESRTIDNCLYFFLENSNTEFVHAQLRINLNEN LSNTEKLLSSFLVELLFQTSVKVINLIGPQISEKYSKLRESKVFLPDVNWSDGEIINFDD FDKLLNTFCIDYYAEFSDGWILDSNTIPNQIKVNWTTPIEYTEFSSILIMSGICGMRLNA ERISTIARTIKGAISELKLSEEGLITSVSNSLCFCDQSIFNISNIPNFDHISKRLIEEPK NYLLELERLHSVLIRPFALGKSEDIPASNTKFSLFVIGKEEANKINLLKYFSINKNYKSQ YLINNQIQSTPNINLLPWEILSKALPLDLGIDFNSNSSQKFRIPEKYGYSIYLKVPSSNT ACFVQSINLNTFGTFCPKGSHFFNPDVPALLVLSNYLWDPCSLLFDSIRGSGLAYSGSLD LCMTTGQFSNCVYESTSIGQSLIKTWEIFRELSMDENEVYEEIKKTNKLPNYYESFYNSL DLDEAKRIAAYKFISKHKKFNSWAKQLNFDLNVGISPKFDSFIIKKISEVTVEDIKRVSI KYLKHFLPNATNMMPSSCIALCGGENSAIDAMEVLKDYPNFRFSVISYSEFLKETLKNVE I
  • Download Fasta
  • MitoProt II - v1.101 File : /home/rajan/sadaf/4480_mitoprot/test/315 Sequence name : 315 Sequence length : 1201 VALUES OF COMPUTED PARAMETERS Coef20 : 3.153 CoefTot : -0.134 ChDiff : -22 ZoneTo : 2 KR : 0 DE : 0 CleavSite : 0 HYDROPHOBIC SCALE USED GES KD GVH1 ECS H17 : 1.512 1.559 0.204 0.556 MesoH : 0.153 0.425 -0.155 0.279 MuHd_075 : 5.585 4.963 3.256 1.624 MuHd_095 : 44.564 29.262 11.211 8.908 MuHd_100 : 48.803 30.743 11.948 9.773 MuHd_105 : 41.259 25.656 9.908 8.279 Hmax_075 : -9.200 2.000 -3.100 1.120 Hmax_095 : 12.100 14.800 0.809 4.980 Hmax_100 : 12.100 14.800 0.809 5.020 Hmax_105 : 0.700 7.962 -1.798 3.482 CLASS NOT-MITO MITO(/CHLORO) DFM : 0.9677 0.0323 DFMC : 0.9701 0.0299
  • ##### ProP v.1.0b ProPeptide Cleavage Site Prediction ##### ##### Furin-type cleavage site prediction (Arginine/Lysine residues) ##### 1201 Chro.80317 MNEVANLFKDELGDLNRGEFIRDETKYNFSFIKSIKVSNVGMLELYQHQKGVIVAFMKTFTICGPSFTHCKLSFTTVPNN 80 NKGIPHALEHVIFNGSKRFPYNDSIDKISNRLCCPYTNAFTIDDSTTFEFECTTEWSLLRMLEVWLDHLFHPILSEESFL 160 TEIVHLNENAEYHGVVYSEVSSFERNYDEVVTTLSKFHTLCESPAEKKKIKLHSTWELYDEITEKYDGSQSSVFSCTGRT 240 TGLQNLSLDELKEFHANFYSLDNMLIFIHGNESININNIFGTIGKFISEAEHVNDNKTCKKIRISDSPINQRPLNRKFCF 320 NENLKEQSFPWHLEIPFPSEEEDLSTISFSWRFGAFSNFKEMLSITVLLHYLCIGNDSPLMKELVEGKSYCSDVDMSNVC 400 EKNRYHQILLQGVETTKINKIVDLFKRIISEFHNGERSFDINDLKCKIEGLYYGHLISLENKTIDTVFNQLSGFINYGIN 480 NMDDLTEYCNLHFIFKKLLSEGLEYWKTLFNKAFCLQKMNILEFVPSKKLSKEMTKRFKEERKERISKKGKRFFQICKAK 560 LEESIIINKKRAISLEILNNFNISFDLNCIDLNKANITTNLNYSEAKLTEINEGNDIIFKKLNMGYDLESRTIDNCLYFF 640 LENSNTEFVHAQLRINLNENLSNTEKLLSSFLVELLFQTSVKVINLIGPQISEKYSKLRESKVFLPDVNWSDGEIINFDD 720 FDKLLNTFCIDYYAEFSDGWILDSNTIPNQIKVNWTTPIEYTEFSSILIMSGICGMRLNAERISTIARTIKGAISELKLS 800 EEGLITSVSNSLCFCDQSIFNISNIPNFDHISKRLIEEPKNYLLELERLHSVLIRPFALGKSEDIPASNTKFSLFVIGKE 880 EANKINLLKYFSINKNYKSQYLINNQIQSTPNINLLPWEILSKALPLDLGIDFNSNSSQKFRIPEKYGYSIYLKVPSSNT 960 ACFVQSINLNTFGTFCPKGSHFFNPDVPALLVLSNYLWDPCSLLFDSIRGSGLAYSGSLDLCMTTGQFSNCVYESTSIGQ 1040 SLIKTWEIFRELSMDENEVYEEIKKTNKLPNYYESFYNSLDLDEAKRIAAYKFISKHKKFNSWAKQLNFDLNVGISPKFD 1120 SFIIKKISEVTVEDIKRVSIKYLKHFLPNATNMMPSSCIALCGGENSAIDAMEVLKDYPNFRFSVISYSEFLKETLKNVE 1200 I 1280 ................................................................................ 80 ................................................................................ 160 ................................................................................ 240 ................................................................................ 320 ................................................................................ 400 ................................................................................ 480 ................................................................................ 560 ................................................................................ 640 ................................................................................ 720 ................................................................................ 800 ................................................................................ 880 ................................................................................ 960 ................................................................................ 1040 ................................................................................ 1120 ................................................................................ 1200 . 1280 Propeptide cleavage sites predicted: Arg(R)/Lys(K): 0 Name Pos Context Score Pred ____________________________v_________________ Chro.80317 9 EVANLFK|DE 0.063 . Chro.80317 17 ELGDLNR|GE 0.080 . Chro.80317 22 NRGEFIR|DE 0.146 . Chro.80317 26 FIRDETK|YN 0.067 . Chro.80317 33 YNFSFIK|SI 0.092 . Chro.80317 36 SFIKSIK|VS 0.066 . Chro.80317 50 ELYQHQK|GV 0.093 . Chro.80317 58 VIVAFMK|TF 0.069 . Chro.80317 71 PSFTHCK|LS 0.065 . Chro.80317 82 TVPNNNK|GI 0.073 . Chro.80317 97 VIFNGSK|RF 0.053 . Chro.80317 98 IFNGSKR|FP 0.149 . Chro.80317 107 YNDSIDK|IS 0.053 . Chro.80317 111 IDKISNR|LC 0.097 . Chro.80317 140 TEWSLLR|ML 0.113 . Chro.80317 185 EVSSFER|NY 0.118 . Chro.80317 196 VVTTLSK|FH 0.053 . Chro.80317 207 CESPAEK|KK 0.064 . Chro.80317 208 ESPAEKK|KI 0.079 . Chro.80317 209 SPAEKKK|IK 0.121 . Chro.80317 211 AEKKKIK|LH 0.071 . Chro.80317 225 YDEITEK|YD 0.069 . Chro.80317 239 VFSCTGR|TT 0.116 . Chro.80317 252 LSLDELK|EF 0.064 . Chro.80317 285 IFGTIGK|FI 0.089 . Chro.80317 297 EHVNDNK|TC 0.061 . Chro.80317 300 NDNKTCK|KI 0.076 . Chro.80317 301 DNKTCKK|IR 0.074 . Chro.80317 303 KTCKKIR|IS 0.107 . Chro.80317 312 DSPINQR|PL 0.079 . Chro.80317 316 NQRPLNR|KF 0.091 . Chro.80317 317 QRPLNRK|FC 0.093 . Chro.80317 325 CFNENLK|EQ 0.055 . Chro.80317 352 TISFSWR|FG 0.116 . Chro.80317 360 GAFSNFK|EM 0.056 . Chro.80317 382 NDSPLMK|EL 0.074 . Chro.80317 388 KELVEGK|SY 0.078 . Chro.80317 402 MSNVCEK|NR 0.069 . Chro.80317 404 NVCEKNR|YH 0.096 . Chro.80317 417 QGVETTK|IN 0.059 . Chro.80317 420 ETTKINK|IV 0.062 . Chro.80317 426 KIVDLFK|RI 0.068 . Chro.80317 427 IVDLFKR|II 0.200 . Chro.80317 437 EFHNGER|SF 0.105 . Chro.80317 445 FDINDLK|CK 0.063 . Chro.80317 447 INDLKCK|IE 0.067 . Chro.80317 462 LISLENK|TI 0.092 . Chro.80317 496 NLHFIFK|KL 0.062 . Chro.80317 497 LHFIFKK|LL 0.137 . Chro.80317 507 EGLEYWK|TL 0.056 . Chro.80317 512 WKTLFNK|AF 0.066 . Chro.80317 518 KAFCLQK|MN 0.059 . Chro.80317 528 LEFVPSK|KL 0.071 . Chro.80317 529 EFVPSKK|LS 0.087 . Chro.80317 532 PSKKLSK|EM 0.061 . Chro.80317 536 LSKEMTK|RF 0.061 . Chro.80317 537 SKEMTKR|FK 0.213 . Chro.80317 539 EMTKRFK|EE 0.063 . Chro.80317 542 KRFKEER|KE 0.099 . Chro.80317 543 RFKEERK|ER 0.071 . Chro.80317 545 KEERKER|IS 0.343 . Chro.80317 548 RKERISK|KG 0.106 . Chro.80317 549 KERISKK|GK 0.125 . Chro.80317 551 RISKKGK|RF 0.083 . Chro.80317 552 ISKKGKR|FF 0.199 . Chro.80317 558 RFFQICK|AK 0.056 . Chro.80317 560 FQICKAK|LE 0.070 . Chro.80317 569 ESIIINK|KR 0.057 . Chro.80317 570 SIIINKK|RA 0.096 . Chro.80317 571 IIINKKR|AI 0.286 . Chro.80317 594 NCIDLNK|AN 0.059 . Chro.80317 607 LNYSEAK|LT 0.078 . Chro.80317 620 GNDIIFK|KL 0.062 . Chro.80317 621 NDIIFKK|LN 0.102 . Chro.80317 631 GYDLESR|TI 0.081 . Chro.80317 654 FVHAQLR|IN 0.073 . Chro.80317 666 NLSNTEK|LL 0.070 . Chro.80317 682 LFQTSVK|VI 0.073 . Chro.80317 694 GPQISEK|YS 0.066 . Chro.80317 697 ISEKYSK|LR 0.063 . Chro.80317 699 EKYSKLR|ES 0.104 . Chro.80317 702 SKLRESK|VF 0.105 . Chro.80317 723 NFDDFDK|LL 0.056 . Chro.80317 752 TIPNQIK|VN 0.060 . Chro.80317 777 SGICGMR|LN 0.081 . Chro.80317 782 MRLNAER|IS 0.093 . Chro.80317 788 RISTIAR|TI 0.134 . Chro.80317 791 TIARTIK|GA 0.216 . Chro.80317 798 GAISELK|LS 0.075 . Chro.80317 833 NFDHISK|RL 0.060 . Chro.80317 834 FDHISKR|LI 0.224 . Chro.80317 840 RLIEEPK|NY 0.061 . Chro.80317 848 YLLELER|LH 0.071 . Chro.80317 855 LHSVLIR|PF 0.097 . Chro.80317 861 RPFALGK|SE 0.073 . Chro.80317 871 IPASNTK|FS 0.070 . Chro.80317 879 SLFVIGK|EE 0.060 . Chro.80317 884 GKEEANK|IN 0.060 . Chro.80317 889 NKINLLK|YF 0.073 . Chro.80317 895 KYFSINK|NY 0.053 . Chro.80317 898 SINKNYK|SQ 0.092 . Chro.80317 923 PWEILSK|AL 0.057 . Chro.80317 940 NSNSSQK|FR 0.073 . Chro.80317 942 NSSQKFR|IP 0.175 . Chro.80317 946 KFRIPEK|YG 0.065 . Chro.80317 954 GYSIYLK|VP 0.063 . Chro.80317 978 FGTFCPK|GS 0.061 . Chro.80317 1009 LLFDSIR|GS 0.109 . Chro.80317 1044 IGQSLIK|TW 0.065 . Chro.80317 1050 KTWEIFR|EL 0.088 . Chro.80317 1064 EVYEEIK|KT 0.063 . Chro.80317 1065 VYEEIKK|TN 0.062 . Chro.80317 1068 EIKKTNK|LP 0.057 . Chro.80317 1086 LDLDEAK|RI 0.065 . Chro.80317 1087 DLDEAKR|IA 0.143 . Chro.80317 1092 KRIAAYK|FI 0.098 . Chro.80317 1096 AYKFISK|HK 0.054 . Chro.80317 1098 KFISKHK|KF 0.066 . Chro.80317 1099 FISKHKK|FN 0.191 . Chro.80317 1105 KFNSWAK|QL 0.076 . Chro.80317 1118 NVGISPK|FD 0.072 . Chro.80317 1125 FDSFIIK|KI 0.086 . Chro.80317 1126 DSFIIKK|IS 0.095 . Chro.80317 1136 VTVEDIK|RV 0.062 . Chro.80317 1137 TVEDIKR|VS 0.198 . Chro.80317 1141 IKRVSIK|YL 0.098 . Chro.80317 1144 VSIKYLK|HF 0.058 . Chro.80317 1176 DAMEVLK|DY 0.067 . Chro.80317 1182 KDYPNFR|FS 0.098 . Chro.80317 1193 SYSEFLK|ET 0.066 . Chro.80317 1197 FLKETLK|NV 0.071 . ____________________________^_________________

  • Fasta :-

    >Chro.80317 ATGAATGAAGTGGCTAATTTATTTAAAGATGAACTTGGGGACTTAAATAGAGGGGAATTT ATTCGAGATGAAACAAAATATAACTTCTCTTTTATTAAATCGATCAAGGTCTCAAATGTT GGAATGTTAGAACTCTACCAACACCAAAAGGGAGTTATTGTAGCATTCATGAAGACTTTT ACTATTTGTGGACCATCTTTTACTCATTGTAAATTAAGTTTTACAACTGTGCCAAACAAC AATAAAGGGATACCGCATGCGCTAGAGCATGTAATTTTTAATGGTAGCAAACGCTTTCCA TATAATGATAGCATTGATAAGATCTCTAACAGACTGTGTTGTCCATACACAAATGCTTTC ACTATAGATGATTCAACTACATTTGAATTTGAATGTACAACAGAATGGAGCCTTTTACGA ATGTTAGAAGTTTGGCTAGATCATTTATTTCATCCAATTTTGTCGGAAGAATCATTTCTT ACAGAGATCGTGCATTTAAATGAAAATGCAGAGTACCATGGAGTAGTTTATTCAGAAGTT TCTTCTTTCGAGAGAAACTATGATGAGGTTGTCACAACTCTTTCAAAGTTTCATACTTTA TGTGAGAGCCCTGCTGAGAAAAAAAAAATCAAGCTTCATTCTACATGGGAACTTTACGAT GAAATCACTGAAAAATATGATGGAAGCCAATCTAGTGTATTTTCATGCACTGGTCGAACA ACTGGACTTCAAAATCTTTCATTAGATGAACTAAAGGAATTTCATGCAAACTTTTATAGT TTGGATAATATGTTAATCTTCATACATGGGAATGAAAGTATTAATATAAATAATATTTTT GGAACAATTGGGAAATTTATTAGCGAAGCAGAACATGTTAATGATAATAAAACCTGTAAG AAAATTAGAATTTCAGATTCCCCAATAAACCAAAGACCATTAAATAGAAAGTTTTGTTTT AATGAAAATTTAAAAGAACAATCTTTTCCATGGCATCTAGAGATCCCATTCCCTAGCGAA GAAGAGGATTTAAGTACCATTAGTTTTTCATGGAGATTTGGAGCATTTTCAAACTTTAAA GAAATGCTATCAATTACCGTATTATTGCATTATTTATGTATTGGAAACGACTCCCCATTG ATGAAAGAACTCGTAGAAGGTAAATCTTACTGTTCAGATGTAGACATGTCAAATGTTTGC GAAAAAAATAGGTACCACCAAATTTTACTTCAGGGGGTAGAAACAACAAAGATTAATAAG ATAGTGGATTTATTTAAGAGAATAATTTCTGAATTCCACAATGGTGAAAGAAGTTTTGAT ATTAATGACTTAAAATGTAAGATAGAAGGTCTATACTACGGACACCTTATTTCATTGGAA AATAAGACTATTGATACAGTATTTAACCAGCTATCTGGTTTTATTAACTATGGAATTAAT AATATGGATGATCTCACCGAATATTGTAATCTGCATTTTATTTTCAAAAAATTGCTTTCA GAGGGATTAGAATATTGGAAAACGCTTTTCAACAAAGCCTTTTGTTTACAAAAAATGAAC ATACTTGAATTTGTTCCAAGCAAAAAATTATCAAAAGAAATGACAAAGAGATTCAAGGAA GAAAGAAAAGAAAGAATAAGTAAGAAAGGTAAACGTTTTTTTCAGATTTGTAAGGCGAAG TTGGAGGAGTCGATAATAATAAATAAAAAACGTGCTATTAGTCTCGAAATACTTAATAAT TTCAATATATCTTTCGATTTAAACTGTATTGATCTTAATAAAGCAAATATTACCACAAAT TTGAATTACTCAGAAGCCAAACTAACAGAGATTAATGAAGGGAACGACATAATATTTAAA AAATTAAATATGGGCTATGACTTAGAATCACGAACAATAGATAATTGTTTGTACTTTTTT TTAGAAAACTCAAATACTGAGTTTGTACACGCACAACTGAGGATTAATTTGAACGAAAAT CTATCTAACACTGAAAAACTACTTTCATCCTTTTTAGTAGAATTATTATTTCAAACATCT GTTAAGGTTATAAATTTAATTGGGCCACAAATTTCTGAAAAATATTCAAAATTAAGAGAG TCAAAAGTCTTCCTACCTGATGTTAATTGGTCAGACGGAGAAATAATTAACTTCGATGAT TTTGATAAACTTTTAAATACTTTTTGTATCGATTACTATGCAGAATTCAGCGATGGATGG ATTTTGGATTCTAATACAATTCCAAACCAAATTAAAGTAAATTGGACAACCCCAATAGAA TATACCGAGTTTTCCTCAATATTAATTATGAGTGGAATTTGTGGCATGAGATTGAATGCT GAAAGAATTTCTACAATAGCCAGAACTATCAAAGGAGCAATCAGCGAACTAAAATTGAGT GAAGAAGGTTTAATTACTTCTGTCTCGAACTCTCTTTGTTTCTGCGATCAATCAATTTTT AATATTTCAAATATTCCAAACTTTGATCATATTTCCAAAAGGTTGATAGAAGAACCAAAA AATTATTTGCTTGAACTAGAAAGGCTTCATTCAGTTCTTATTAGACCATTCGCTCTTGGG AAATCAGAAGATATTCCAGCCAGTAACACAAAGTTTTCGTTATTTGTTATTGGGAAAGAG GAGGCCAACAAAATAAATTTATTGAAATATTTTTCTATCAATAAAAACTACAAAAGCCAA TACTTAATTAATAACCAAATACAGAGCACTCCCAACATAAATTTACTTCCATGGGAAATA CTTTCAAAAGCACTCCCATTGGATCTAGGTATAGACTTTAATTCAAACAGCTCACAAAAA TTTAGAATACCTGAAAAATATGGCTATTCAATTTACCTAAAGGTTCCAAGCTCAAATACA GCGTGTTTTGTTCAGTCAATCAATTTAAATACATTTGGTACTTTCTGCCCAAAAGGATCT CATTTTTTCAATCCAGATGTTCCAGCTCTTCTTGTACTTTCAAACTATCTTTGGGATCCT TGCTCACTACTCTTTGATTCAATTAGGGGCAGTGGTTTAGCATATAGTGGAAGTTTAGAT CTTTGTATGACTACTGGACAGTTTTCAAATTGTGTGTATGAATCAACATCAATTGGTCAA TCTTTAATCAAGACTTGGGAAATTTTCAGAGAGTTATCAATGGATGAAAATGAGGTTTAT GAAGAGATTAAGAAAACTAACAAATTACCTAATTACTATGAAAGCTTTTATAACAGTCTA GATCTTGATGAAGCAAAAAGGATCGCTGCTTATAAATTTATTTCAAAGCACAAAAAATTC AATTCTTGGGCAAAACAGCTAAATTTTGATCTCAATGTTGGTATTTCTCCAAAATTTGAC AGTTTTATTATTAAAAAAATATCAGAAGTTACAGTTGAAGATATAAAAAGAGTTTCAATC AAGTACCTTAAACATTTCTTACCTAATGCCACAAATATGATGCCTTCAAGTTGCATAGCT CTTTGCGGTGGAGAAAATTCTGCTATTGATGCAATGGAAGTTCTAAAGGATTACCCAAAT TTTAGATTTAGTGTCATTTCATACTCTGAATTTTTAAAAGAAACACTAAAAAATGTTGAA ATTTAG
  • Download Fasta

  • Fasta :-

    MNEVANLFKDELGDLNRGEFIRDETKYNFSFIKSIKVSNVGMLELYQHQKGVIVAFMKTF TICGPSFTHCKLSFTTVPNNNKGIPHALEHVIFNGSKRFPYNDSIDKISNRLCCPYTNAF TIDDSTTFEFECTTEWSLLRMLEVWLDHLFHPILSEESFLTEIVHLNENAEYHGVVYSEV SSFERNYDEVVTTLSKFHTLCESPAEKKKIKLHSTWELYDEITEKYDGSQSSVFSCTGRT TGLQNLSLDELKEFHANFYSLDNMLIFIHGNESININNIFGTIGKFISEAEHVNDNKTCK KIRISDSPINQRPLNRKFCFNENLKEQSFPWHLEIPFPSEEEDLSTISFSWRFGAFSNFK EMLSITVLLHYLCIGNDSPLMKELVEGKSYCSDVDMSNVCEKNRYHQILLQGVETTKINK IVDLFKRIISEFHNGERSFDINDLKCKIEGLYYGHLISLENKTIDTVFNQLSGFINYGIN NMDDLTEYCNLHFIFKKLLSEGLEYWKTLFNKAFCLQKMNILEFVPSKKLSKEMTKRFKE ERKERISKKGKRFFQICKAKLEESIIINKKRAISLEILNNFNISFDLNCIDLNKANITTN LNYSEAKLTEINEGNDIIFKKLNMGYDLESRTIDNCLYFFLENSNTEFVHAQLRINLNEN LSNTEKLLSSFLVELLFQTSVKVINLIGPQISEKYSKLRESKVFLPDVNWSDGEIINFDD FDKLLNTFCIDYYAEFSDGWILDSNTIPNQIKVNWTTPIEYTEFSSILIMSGICGMRLNA ERISTIARTIKGAISELKLSEEGLITSVSNSLCFCDQSIFNISNIPNFDHISKRLIEEPK NYLLELERLHSVLIRPFALGKSEDIPASNTKFSLFVIGKEEANKINLLKYFSINKNYKSQ YLINNQIQSTPNINLLPWEILSKALPLDLGIDFNSNSSQKFRIPEKYGYSIYLKVPSSNT ACFVQSINLNTFGTFCPKGSHFFNPDVPALLVLSNYLWDPCSLLFDSIRGSGLAYSGSLD LCMTTGQFSNCVYESTSIGQSLIKTWEIFRELSMDENEVYEEIKKTNKLPNYYESFYNSL DLDEAKRIAAYKFISKHKKFNSWAKQLNFDLNVGISPKFDSFIIKKISEVTVEDIKRVSI KYLKHFLPNATNMMPSSCIALCGGENSAIDAMEVLKDYPNFRFSVISYSEFLKETLKNVE I

    No Results
No Results
No Results
IDSitePeptideScoreMethodIDSitePeptideScoreMethodIDSitePeptideScoreMethodIDSitePeptideScoreMethodIDSitePeptideScoreMethodIDSitePeptideScoreMethodIDSitePeptideScoreMethodIDSitePeptideScoreMethod
Chro.80317547 SKERISKKGK0.998unspChro.80317547 SKERISKKGK0.998unspChro.80317547 SKERISKKGK0.998unspChro.80317701 SKLRESKVFL0.99unspChro.803171053 SFRELSMDEN0.996unspChro.803171139 SIKRVSIKYL0.996unspChro.80317307 SRISDSPINQ0.996unspChro.80317531 SSKKLSKEMT0.997unsp

Chro.80317      



Dinesh Gupta lab Translational bioinformatics group, ICGEB, New Delhi, India